Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    84.05
    +0.48 (+0.57%)
     
  • GOLD

    2,359.30
    +16.80 (+0.72%)
     
  • Bitcoin AUD

    98,198.89
    +797.40 (+0.82%)
     
  • CMC Crypto 200

    1,388.33
    -8.21 (-0.59%)
     
  • AUD/EUR

    0.6089
    +0.0016 (+0.26%)
     
  • AUD/NZD

    1.0979
    +0.0022 (+0.20%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,105.76
    +26.90 (+0.33%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,044.17
    +126.89 (+0.71%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

2 of the Safest Stocks to Buy in a Recession

Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top-selling drugs, there's a good chance that AbbVie stock will remain a safe haven even if the U.S. economy plunges into a deep recession. The top-selling drug for AbbVie is Humira.